Literature DB >> 21173015

Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis.

Laura Obici, Antonella Meini, Marco Cattalini, Silvana Chicca, Marco Galliani, Simona Donadei, Alessandro Plebani, Giampaolo Merlini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21173015     DOI： 10.1136/ard.2010.143438

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  26 in total

Review 1.  Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.

Authors:  R Goldbach-Mansky
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 2.  Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature.

Authors:  Stefano Gentileschi; Donato Rigante; Antonio Vitale; Jurgen Sota; Bruno Frediani; Mauro Galeazzi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2017-05-23       Impact factor: 2.980

Review 3.  Biologic modulators in allergic and autoinflammatory diseases.

Authors:  Lori Broderick; Louanne M Tourangeau; Arthur Kavanaugh; Stephen I Wasserman
Journal:  Curr Opin Allergy Clin Immunol       Date:  2011-08

Review 4.  Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome.

Authors:  Donato Rigante; Giuseppe Lopalco; Antonio Vitale; Orso Maria Lucherini; Caterina De Clemente; Francesco Caso; Giacomo Emmi; Luisa Costa; Elena Silvestri; Laura Andreozzi; Florenzo Iannone; Mauro Galeazzi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2014-06-17       Impact factor: 2.980

Review 5.  Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists' lens.

Authors:  Marco Cattalini; Martina Soliani; Giuseppe Lopalco; Donato Rigante; Luca Cantarini
Journal:  Intern Emerg Med       Date:  2016-05-25       Impact factor: 3.397

6.  Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies.

Authors:  Susannah D Brydges; Lori Broderick; Matthew D McGeough; Carla A Pena; James L Mueller; Hal M Hoffman
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

7.  Anakinra treatment in drug-resistant Behcet's disease: a case series.

Authors:  Luca Cantarini; Antonio Vitale; Perla Scalini; Charles A Dinarello; Donato Rigante; Rossella Franceschini; Gabriele Simonini; Giulia Borsari; Francesco Caso; Orso Maria Lucherini; Bruno Frediani; Ilaria Bertoldi; Leonardo Punzi; Mauro Galeazzi; Rolando Cimaz
Journal:  Clin Rheumatol       Date:  2013-12-05       Impact factor: 2.980

Review 8.  Tumor necrosis factor receptor-associated periodic syndrome as a model linking autophagy and inflammation in protein aggregation diseases.

Authors:  Tiziana Bachetti; Isabella Ceccherini
Journal:  J Mol Med (Berl)       Date:  2014-04-06       Impact factor: 4.599

Review 9.  Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives.

Authors:  Giulia Di Donato; Debora Mariarita d'Angelo; Luciana Breda; Francesco Chiarelli
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

10.  First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS).

Authors:  Orso Maria Lucherini; Laura Obici; Manuela Ferracin; Valerio Fulci; Michael F McDermott; Giampaolo Merlini; Isabella Muscari; Flora Magnotti; Laura J Dickie; Mauro Galeazzi; Massimo Negrini; Cosima Tatiana Baldari; Rolando Cimaz; Luca Cantarini
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.